Literature DB >> 25619647

Is lower zone mediastinal nodal dissection always mandatory for lung cancer in the lower lobe?

Hiroyasu Ueno1, Aritoshi Hattori2, Takeshi Matsunaga2, Kazuya Takamochi2, Shiaki Oh2, Kenji Suzuki3.   

Abstract

PURPOSE: Dissection of the lower zone mediastinal nodes is mandatory during systematic nodal dissection for lung cancer. However, the significance of lower zone lymph node metastasis (LZM) in lung cancer remains unclear. Therefore, we aimed to identify the predictive factors for LZM in patients with lower lobe lung cancer.
METHODS: A retrospective study was conducted on 257 patients with lower lobe lung cancer, in whom pulmonary resection and mediastinal nodal dissection were performed between 2009 and 2013. The radiological factors on thin-section computed tomography scans (TSCT) and several conventional clinical factors were evaluated as possible predictors of LZM.
RESULTS: Twenty (7.8 %) patients exhibited LZM. The majority of the tumors were especially located in segment 10 (50 %). All patients showed a solid appearance on TSCT. In a univariate analysis, the tumor location, a solid appearance and the clinical T factor significantly predicted LZM (p = 0.011, 0.005, 0.018). Furthermore, based on a multivariate analysis, the tumor location in segment 10 significantly predicted LZM in patients with lower lobe solid lung cancer (p = 0.031).
CONCLUSION: The appropriate surgical strategy for lower zone lymph node dissection should be selected based on the tumor location and the findings of TSCT, due to the high frequency of LZM (19.6 %), especially in patients with pure solid lung cancer in segment 10.

Entities:  

Keywords:  Lower zone lymph node; Lung cancer; Lymph node dissection; Predictive factor

Mesh:

Year:  2015        PMID: 25619647     DOI: 10.1007/s00595-014-1105-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  27 in total

1.  Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  K Takamochi; K Nagai; J Yoshida; K Suzuki; Y Ohde; M Nishimura; S Sasaki; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

Review 2.  Sentinel nodes in lung cancer: review of our 10-year experience.

Authors:  Hiroaki Nomori; Mitsutomo Kohno; Yotaro Izumi; Takashi Ohtsuka; Keisuke Asakura; Takashi Nakayama
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

3.  Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact.

Authors:  Kenji Suzuki; Masahiko Kusumoto; Shun-ichi Watanabe; Ryosuke Tsuchiya; Hisao Asamura
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

4.  Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.

Authors:  S M Keller; S Adak; H Wagner; D H Johnson
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

5.  A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).

Authors:  Kenji Suzuki; Teruaki Koike; Takashi Asakawa; Masahiko Kusumoto; Hisao Asamura; Kanji Nagai; Hirohito Tada; Tetsuya Mitsudomi; Masahiro Tsuboi; Taro Shibata; Haruhiko Fukuda; Harubumi Kato
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

6.  A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

Authors:  Yi long Wu; Zhi-fan Huang; Si-yu Wang; Xue-ning Yang; Wei Ou
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

7.  Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.

Authors:  Marc Riquet; Jalal Assouad; Patrick Bagan; Christophe Foucault; Françoise Le Pimpec Barthes; Antoine Dujon; Claire Danel
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

8.  Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.

Authors:  Haruhisa Matsuguma; Kohei Yokoi; Masaki Anraku; Tetsuro Kondo; Yukari Kamiyama; Kiyoshi Mori; Keigo Tominaga; Yukio Tsuura; Satoshi Honjo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-08       Impact factor: 5.209

9.  Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.

Authors:  Steven M Keller; Mark G Vangel; Henry Wagner; Joan H Schiller; Arnold Herskovic; Ritsuko Komaki; Randolph S Marks; Michael C Perry; Robert B Livingston; David H Johnson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-07       Impact factor: 5.209

10.  The presence of air bronchogram is a novel predictor of negative nodal involvement in radiologically pure-solid lung cancer.

Authors:  Aritoshi Hattori; Kenji Suzuki; Tatsuo Maeyashiki; Mariko Fukui; Yoshitaka Kitamura; Takeshi Matsunaga; Yoshikazu Miyasaka; Kazuya Takamochi; Shiaki Oh
Journal:  Eur J Cardiothorac Surg       Date:  2013-10-17       Impact factor: 4.191

View more
  1 in total

1.  Detection of alternative subpleural lymph flow pathways using indocyanine green fluorescence.

Authors:  Aya Harada Takeda; Yui Watanabe; Toshiyuki Nagata; Masaya Aoki; Tadashi Umehara; Soichi Suzuki; Go Kamimura; Kazuhiro Wakida; Tsunayuki Otsuka; Naoya Yokomakura; Kota Kariatsumari; Koichi Sakasegawa; Yoshihiro Nakamura; Masami Sato
Journal:  Surg Today       Date:  2018-01-30       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.